Back
GraniteShares 2x Long META Daily ETF Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Sell
35
FBL
GraniteShares 2x Long META Daily ETF
Last Price:
$34.05
Seasonality Move:
37.55%
Buy
60
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.61
Seasonality Move:
-4.31%
Sell
35
GraniteShares 2x Long META Daily ETF (FBL)
is a Sell
Is GraniteShares 2x Long META Daily ETF a Buy, Sell or Hold?
-
The current GraniteShares 2x Long META Daily ETF [FBL] share price is $34.04. The Score for FBL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
FBL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.69. The Score for GPCR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FBL Stock Price Chart
What is GraniteShares 2x Long META Daily ETF's stock price today?
-
The GraniteShares 2x Long META Daily ETF share price today is $34.04The current trend is relatively stagnant and FBL is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.
FBL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 55.26 | Buy |
| Chaikin Money Flow: | 776887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.41 - 33.95) | Buy |
| Bollinger Bands (100): | (32.7 - 47.22) | Sell |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.55 | Buy |
| Relative Strength Index (14 RSI): | 70.17 | Buy |
| Chaikin Money Flow: | -284110 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.64 - 66.86) | Buy |
| Bollinger Bands (100): | (17.09 - 46.21) | Buy |
FBL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.96 | Buy |
| 20-day SMA: | 32.71 | Buy |
| 50-day SMA: | 34.06 | Sell |
| 200-day SMA: | 37.73 | Sell |
| 8-day EMA: | 33.23 | Buy |
| 20-day EMA: | 32.75 | Buy |
| 50-day EMA: | 34.42 | Sell |
| 200-day EMA: | 37.3 | Sell |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.76 | Buy |
| 20-day SMA: | 54.7 | Buy |
| 50-day SMA: | 41.07 | Buy |
| 200-day SMA: | 26.34 | Buy |
| 8-day EMA: | 65.27 | Buy |
| 20-day EMA: | 57.2 | Buy |
| 50-day EMA: | 45.22 | Buy |
| 200-day EMA: | 31.64 | Buy |
GraniteShares 2x Long META Daily ETF Earnings Growth & FBL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
GraniteShares 2x Long META Daily ETF Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||